国家卫健委:无症状感染者有传染性

2020-04-01 新华社 新华社

国家卫健委31日在官网发布《关于新型冠状病毒无症状感染者的防控工作答问》,对近来网民热议的无症状感染者相关问题进行回答。

国家卫健委31日在官网发布《关于新型冠状病毒无症状感染者的防控工作答问》,对近来网民热议的无症状感染者相关问题进行回答。数据显示,截至2020年3月30日24时,接受医学观察的无症状感染者为1541例,其中境外输入205例。

文章提到,根据国家和部分省份开展的密切接触者监测数据,无症状感染者的密切接触者存在二代病例续发,流行病学调查中发现个别由无症状感染者导致的聚集性疫情,有小样本量的研究显示无症状感染者呼吸道样本中的病毒载量与确诊病例没有太大差异。

综合目前的监测和研究,无症状感染者存在传染性,但其传染期长短、传染性强弱、传播方式等尚需开展进一步科学研究。部分专家认为鉴于无症状感染者的呼吸道标本能检出病原核酸,但由于无咳嗽、打喷嚏等临床症状,病原排出体外引起传播的机会较确诊病例相对少一些。

文章提到,新冠病毒无症状感染者是指无相关临床症状,如发热、咳嗽、咽痛等可自我感知或可临床识别的症状与体征,但呼吸道等标本新冠病毒病原学检测阳性者。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1911514, encodeId=45e01911514c4, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Dec 05 02:26:25 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258729, encodeId=af7f1258e2943, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291277, encodeId=8eed12912e7f9, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba5f232, createdName=zhao4616, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353258, encodeId=fb6d1353258b8, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485075, encodeId=3bc914850e588, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=)]
    2020-12-05 xzw113
  2. [GetPortalCommentsPageByObjectIdResponse(id=1911514, encodeId=45e01911514c4, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Dec 05 02:26:25 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258729, encodeId=af7f1258e2943, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291277, encodeId=8eed12912e7f9, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba5f232, createdName=zhao4616, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353258, encodeId=fb6d1353258b8, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485075, encodeId=3bc914850e588, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1911514, encodeId=45e01911514c4, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Dec 05 02:26:25 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258729, encodeId=af7f1258e2943, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291277, encodeId=8eed12912e7f9, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba5f232, createdName=zhao4616, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353258, encodeId=fb6d1353258b8, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485075, encodeId=3bc914850e588, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1911514, encodeId=45e01911514c4, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Dec 05 02:26:25 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258729, encodeId=af7f1258e2943, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291277, encodeId=8eed12912e7f9, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba5f232, createdName=zhao4616, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353258, encodeId=fb6d1353258b8, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485075, encodeId=3bc914850e588, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1911514, encodeId=45e01911514c4, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Dec 05 02:26:25 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258729, encodeId=af7f1258e2943, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291277, encodeId=8eed12912e7f9, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba5f232, createdName=zhao4616, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353258, encodeId=fb6d1353258b8, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485075, encodeId=3bc914850e588, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Apr 03 07:26:25 CST 2020, time=2020-04-03, status=1, ipAttribution=)]

相关资讯

春夏外出 小心引“蜱”上身

春暖花开,听起来很美好,可是你造么,随着气温的逐渐上升,微生物的生长繁殖速度加快,危险就在你不留神时。一提到春天踏青,大部分中国人都会有“乱花渐欲迷人眼,浅草才能没马蹄”的美好想象,可是你造么,草丛、动物皮毛、枯枝落叶里有无数双眼睛在紧紧盯着你,它就是--“蜱虫”! (图片来自网络) 蜱之浅识——草丛中的吸血鬼 蜱(pí)是许多种脊椎动物体表的暂时

Am J Res Cri Care Med: 热点:临床症状消失8天后仍有传染性,全球疫情形式严峻!

为了弄清病毒清除和症状分解的时间动力学,研究人员选取了2020年1月28日至2月9日从中国人民解放军总医院治疗中心发布的所有16例确诊的COVID-19患者为研究对象进行研究。所有患者在隔日收集了咽拭

NEJM:疥疮-案例报道

女性,61岁,出现严重的瘙痒性皮疹6月余。该女患者主诉在其腹部、背部、手臂和腿等多处出现黄色结痂。曾应用过醋酸氟轻松乳膏和强力霉素进行为期4周的治疗,但皮疹现象未见明显的好转。

Lancet:囊肿性纤维化患者易感染脓肿分枝杆菌且具传染性

研究人员称:在囊肿性纤维化患者引起其肺部感染的细菌种类日益增多,这些细菌可以通过人与人之间进行传播的,尽管可能不是直接接触性的传播。 据在英国 Hinxton,威康信托桑格研究所(Wellcome Trust Sanger Institute)的博士朱利安·帕克希尔(Julian Parkhill)及其同事们称:分离来自感染囊性纤维化患者的集中性脓肿分枝杆菌的基因组分析发现几乎没有序列的差异。事

韩国人带来的MERS病毒,最终在中国大规模爆发的可能性有多高?

上周五,中国在广东省确诊了首例中东呼吸综合征(MERS)病例。目前确诊的韩国MERS患者已经在该省跟77人发生过亲密接触,这名患者无视旅行警示,并在飞往中国时隐瞒了自己的病情。截至6月1日,其中64人已被隔离,而其余13人至今仍没有被找到。在中国,大家对当年的非典型肺炎(SARS,以下简称非典)疫情仍然记忆犹新,再加上MERS跟非典之间存在相似之处,在这种情况下,很多人担心中国可能爆发类似的MER